Skip to main content


The Dr. M. Daria Haust Pathology Summer Studentship

1 September 2020
1st and 2nd year Medical Students@Queen’s University

Re: The Dr. M. Daria Haust Pathology Summer Studentship

I would like to encourage all medical students in first or second years to consider applying to the Dr. M. Daria Haust Pathology Summer Studentship. This opportunity is generously funded by a donation from Dr. M. Daria Haust, a Pathologist and Queen’s alumnus and provides $4,500 in funding for students to undertake a 10-week studentship in the Queen’s Department of Pathology and Molecular Medicine. There is considerable flexibility in structure of the studentship depending on the interests of the successful candidate. Typically, there is a combination of participation in one or more areas of clinical pathology (e.g. autopsy service, surgical pathology, molecular diagnostics or other clinical labs) plus involvement in a research project or critical enquiry under the supervision of a faculty member.

Complete information and application form here.

Best Departmental Research seminars of 2019-2020

Best Departmental Research seminars of 2019-2020

Congratulations to Michael Luo, Ivan Shapovalov and Julie Tarrant for winning the awards for the best Departmental Research seminars of 2019-2020 by a 1st year Student, 2nd year student or PhD student, respectively. 

In addition to a handsome commemorative certificate, each will receive a $300 prize from the Robert Kisilevsky Research Education Fund.  We are proud of the accomplishments of these exceptional trainees and wish them success in their future endeavors. 


Posted: 3 September 2020

The Department of Pathology and Molecular Medicine in the Queen’s University Faculty of Health
Sciences is recruiting to a Term Adjunct appointment to coordinate and teach PATH-411.
Pathology and Molecular Medicine

PATH-411 – Applied Data Science in Molecular Medicine (100% responsibility)
This course is intended to be an in-class course, but may require remote or online delivery depending
on Queen’s University and public health guidelines at time of offering.
Lectures, student presentation and student-led teaching sessions

2021 and will end 30 April 2021.

To comply with Federal laws, the University is obliged to gather statistical information about how
many applicants for each job vacancy are Canadian citizens / permanent residents of Canada.
Applicants need not identify their country of origin or citizenship; however, all applications must
include one of the following statements: “I am a Canadian citizen / permanent resident of Canada”;
OR, “I am not a Canadian citizen / permanent resident of Canada”. Applications that do not include
this information will be deemed incomplete.

Academic staff at Queen’s University are governed by a Collective Agreement between the Queen’s
University Faculty Association (QUFA) and the University, which is posted at

The University will provide support in its recruitment processes to applicants with disabilities,
including accommodation that takes into account an applicant’s accessibility needs. If you require
accommodation during the interview process, please contact Barb Latimer at

Deadline for receipt of applications is 18 September 2020 by 4:00 pm. Applicants should submit a letter
of interest, a complete and current curriculum vitae, any other relevant materials (such as a teaching
dossier) and the names and contact information of two referees who may be contacted to:
Dr. Alexander Boag, Head, Department of Pathology and Molecular Medicine, Queen's University,
Kingston, Ontario K7L 3N6 (c/o Barb Latimer) (Tel): (613) 533-2850; E-mail:
(electronic submission preferred). URL:

 Jina Nanayakkara

Congratulations to Jina Nanayakkara

Congratulations to Jina Nanayakkara, MD/PhD candidate in Dr. Neil Renwick’s group, on winning a Silver award of excellence at the CIHR National Research Poster presentation on August 25th. 

Jina’s presentation entitled “MicroRNA-based classification of neuroendocrine neoplasms” describe how she has used miRNA expression to define a signature that accurately diagnoses neuroendocrine tumors. 

These exciting results provide the basis of a new and highly efficient test to identify these tumors and to inform clinical management. 

Also, join me in congratulating Jina in publishing this story in NAR Cancer last month.